Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can one extra stitch make Weight-Loss surgery kinder to the gut?

NCT ID NCT07861529

Symptom relief Sponsor: Helwan University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Oct 06, 2026 · Last updated Oct 07, 2026 · Updated 1 time

Summary

Researchers compare two versions of laparoscopic sleeve gastrectomy in adults with obesity and reflux symptoms. One group receives standard surgery, and the other receives surgery plus posterior gastropexy, a step that stitches the stomach to the back wall to discourage reflux. The trial tracks gastrointestinal quality of life and body mass index over 12 months to see whether the added step helps.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
posterior gastropexy, a surgical step added to laparoscopic sleeve gastrectomy
What this could lead to
If it helps, adding posterior gastropexy could become a routine step in sleeve gastrectomy to reduce reflux and improve quality of life after surgery.
What could go wrong
This is a small pilot trial of 50 people at a single sponsor, so any benefit may not hold up in larger studies. Surgery carries risks such as bleeding, leakage, infection, and reflux that persists or worsens.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

50 people

The number who actually took part.

Started

Mar 2023

Finished

Apr 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 65 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patients aged 18 to 65 years scheduled for elective laparoscopic sleeve gastrectomy. * Body Mass Index (BMI) of 35 kg/m² or greater. * Presence of preoperative symptoms or documentation of gastroesophageal reflux disease (GERD). * Able to provide informed consent. Exclusion Criteria: * Previous history of bariatric or upper gastrointestinal surgery. * Large hiatal hernia requiring formal repair. * Contraindications to general anesthesia or laparoscopy. * Pregnant or lactating females.Inclusion Criteria:

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Gastroesophageal reflux disease are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

gastroesophageal reflux disease Obesity obesity disorder Overweight

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Obesity & overweight

Contacts and locations

Locations

  • Helwan University

    Cairo, Cairo Governorate, 11828, Egypt

More trials for these conditions

Other studies related to the condition(s) this trial covers.